z-logo
open-access-imgOpen Access
Effects of Endothelial Dysfunction on Residual Platelet Aggregability After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease
Author(s) -
Koichiro Fujisue,
Seigo Sugiyama,
Takamichi Ono,
Yasushi Matsuzawa,
Eiichi Akiyama,
Koichi Sugamura,
Junichi Matsubara,
Hirofumi Kurokawa,
Koichi Kaikita,
Satomi Iwashita,
Hitoshi Sumida,
Seiji Hokimoto,
Kentaro Oniki,
Kazuko Nakagawa,
Kunihiko Matsui,
Hisao Ogawa
Publication year - 2013
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.112.000278
Subject(s) - medicine , reactive hyperemia , clopidogrel , aspirin , p2y12 , cardiology , coronary artery disease , endothelial dysfunction , platelet activation , platelet , cyp2c19 , blood flow , cytochrome p450 , metabolism
Dual antiplatelet therapy with aspirin and clopidogrel is widely used in patients with coronary stents. High residual platelet reactivity (high RPR) after dual antiplatelet therapy is associated with increased cardiovascular events. Endothelial function could affect platelet reactivity in vivo. We hypothesized that endothelial dysfunction could be associated with high RPR after dual antiplatelet therapy in patients with stable coronary artery disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom